Heptromic. Genomic predictors and oncogenic drivers in hepatocellurlar carcinoma

  • Heptromic Genomic predictors and oncogenic drivers in hepatocellular carcinoma. Watch the video
  • Heptromic will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
  • Heptromic’s core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
  • Heptromic is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.

News

More news

RSS

Events

More events

RSS

Scientific Publications

More scientific publications

Heptromic Partners

IDIBAPS-Hospital Clínic Barcelona

Dr. Josep Maria Llovet

IDIBAPS-Hospital Clínic Barcelona

Staff IDIBAPS

Project coordination. Genomic & kinome profiling.

Project led by: Idibaps

Copyright © 2010 - 2017 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.